Stephan Laux has more than 25 years of global CRO and pharmaceutical experience in a wide range of therapeutic areas, with concentrated expertise in oncology and hematology, dermatology, rheumatology, transplant medicine, and infectious diseases. He joined Premier Research in 2008 as a project manager and led numerous international and global clinical trials prior to assuming his current position in 2016.
Dr. Laux has an extensive oncology background and maintains a large network of key opinion leaders in the field. He has led many oncology trials, from Phase I to Phase III, with a focus on hematological oncology, non-Hodgkin lymphoma, and prostate cancer, and has a special interest in PK/PD models and PK simulation models.
Prior to joining Premier Research, Dr. Laux held program management positions at PPD, Hesperion International, and Medifacts International, and worked as a clinical trial leader and clinical research associate. He holds a Ph.D. from the University of Heidelberg in Germany and is a member of the Union for International Cancer Control and the German Cancer Aid Foundation.